71 related articles for article (PubMed ID: 1934666)
1. Intragastric long-term pH-metry in hemodialysis patients. A study with famotidine.
Gladziwa U; Wagner S; Dakshinamurty KV; Bechtel B; Mann H; Sieberth HG
Clin Nephrol; 1991 Aug; 36(2):97-102. PubMed ID: 1934666
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic control of premedication with famotidine given on the evening before surgery for the prevention of pneumonitis in heart surgery patients].
Heim J; Müller V; Hummel M; Hetzer R; Adt M
Anaesthesist; 1992 Apr; 41(4):165-70. PubMed ID: 1590572
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of single morning and single bedtime doses of famotidine on intragastric acidity in patients with gastric ulcer.
Arita M; Okada M; Motomura A; Matsui T; Hosiko K; Yao T
Am J Gastroenterol; 1994 Feb; 89(2):214-9. PubMed ID: 8304306
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
Bisson C; St-Laurent M; Michaud JT; LeBel M
Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
[TBL] [Abstract][Full Text] [Related]
6. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
Löser C; Burlage M; Fölsch UR
Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
8. Can famotidine and omeprazole be combined on a once-daily basis?
Fändriks L; Lönroth H; Pettersson A; Vakil N
Scand J Gastroenterol; 2007 Jun; 42(6):689-94. PubMed ID: 17505990
[TBL] [Abstract][Full Text] [Related]
9. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
10. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of famotidine in infants.
James LP; Marotti T; Stowe CD; Farrar HC; Taylor BJ; Kearns GL
J Clin Pharmacol; 1998 Dec; 38(12):1089-95. PubMed ID: 11301560
[TBL] [Abstract][Full Text] [Related]
13. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
16. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients.
Heiselman DE; Hulisz DT; Fricker R; Bredle DL; Black LD
Am J Gastroenterol; 1995 Feb; 90(2):277-9. PubMed ID: 7847300
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
